VIVOSIM LABS INC (VIVS) Stock News

USA - Nasdaq - NASDAQ:VIVS - US68620A3023 - Common Stock

1.95 USD

-0.27 (-12.16%)

Last: 12/15/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

VIVS Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Benzinga - Mentions: HBIO GH INTS GKOS ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

2 months ago - By: Benzinga - Mentions: NXPL VCIG EBAY CERO ...

Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

4 months ago - By: VivoSim Labs, Inc.

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

4 months ago - By: VivoSim Labs, Inc.

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

4 months ago - By: Yahoo Finance - Mentions: NIO

Nio Inc. (NIO) umbles 8% as Slow July Deliveries Growth Disappoint

7 months ago - By: VivoSim Labs, Inc.

VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

7 months ago - By: VivoSim Labs, Inc.

VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

7 months ago - By: VivoSim Labs, Inc.

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

7 months ago - By: VivoSim Labs, Inc.

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

8 months ago - By: VivoSim Labs, Inc. - Mentions: ONVO

VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market

8 months ago - By: VivoSim Labs, Inc. - Mentions: ONVO

VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market